Factory planning for water bottling projects
Decision guide | operations
Place potentially affected product on hold and preserve the original result, samples and records. Review laboratory execution without assuming error, then examine source, treatment, environment, packaging and distribution evidence needed to explain the result and set a justified lot boundary. Retesting may be scientifically appropriate but cannot be used to test into compliance. Qualified quality personnel and applicable authority rules control confirmation, notification, disposition and release.
01
Place potentially affected product on hold and preserve the original result, samples and records. Review laboratory execution without assuming error, then examine source, treatment, environment, packaging and distribution evidence needed to explain the result and set a justified lot boundary. Begin with immediate batch hold: document immediate batch hold from current site evidence; name the owner, source and review date. Use result transcription check next. Test normal and credible adverse result transcription check conditions; state the exception and stop rule. Close the method and instrument review stage through method and instrument review evidence, specifically a method and instrument review interface map with closed gaps or named owners and due dates.
Document immediate batch hold from current site evidence; name the owner, source and review date. Immediate batch hold risk: weak immediate batch hold evidence leaves ownership and the decision basis unclear. Retain a dated immediate batch hold basis with source, owner, status and approval.
Test normal and credible adverse result transcription check conditions; state the exception and stop rule. Result transcription check risk: incompatible result transcription check can block startup or permit an unsafe release. Retain a result transcription check test showing conditions, raw result, exception and disposition.
Trace method and instrument review across physical and responsibility interfaces; close or assign every dependency. Method and instrument review risk: unmapped method and instrument review leaves an interface outside effective control. Retain a method and instrument review interface map with closed gaps or named owners and due dates.
02
At sample integrity, control the approved sample integrity basis and reopen it after a relevant process, material or site change. Set analyst assessment beside sample integrity; observe analyst assessment at the decision point with a named method and verified instrument status. Source history decides the case. Untested source history can fail when routine conditions vary. The sample integrity table entry pairs its action with the controlled sample integrity revision and its requalification trigger; the risk for analyst assessment is that poorly located analyst assessment can hide deterioration until product is affected.
Control the approved sample integrity basis and reopen it after a relevant process, material or site change. For Sample integrity, compare the result against the controlled sample integrity revision and its requalification trigger; reject the option if outdated sample integrity separates the approved basis from the installed condition.
Observe analyst assessment at the decision point with a named method and verified instrument status. For Analyst assessment, compare the result against the analyst assessment location rationale, method and instrument status; reject the option if poorly located analyst assessment can hide deterioration until product is affected.
Challenge source history at startup and stable production, then reconcile any difference. For Source history, compare the result against startup and stable source history results with approved exceptions; reject the option if untested source history can fail when routine conditions vary.
| Bottled Water Out-of-Specification Investigation factor | Immediate batch hold action | Result transcription check failure | Method and instrument review retained evidence |
|---|---|---|---|
| Immediate batch hold | Document immediate batch hold from current site evidence; name the owner, source and review date | weak immediate batch hold evidence leaves ownership and the decision basis unclear | a dated immediate batch hold basis with source, owner, status and approval |
| Result transcription check | Test normal and credible adverse result transcription check conditions; state the exception and stop rule | incompatible result transcription check can block startup or permit an unsafe release | a result transcription check test showing conditions, raw result, exception and disposition |
| Method and instrument review | Trace method and instrument review across physical and responsibility interfaces; close or assign every dependency | unmapped method and instrument review leaves an interface outside effective control | a method and instrument review interface map with closed gaps or named owners and due dates |
| Sample integrity | Control the approved sample integrity basis and reopen it after a relevant process, material or site change | outdated sample integrity separates the approved basis from the installed condition | the controlled sample integrity revision and its requalification trigger |
03
Control starts with treatment trends, passes through hygiene and environment, then tests packaging lot review. A failure of treatment trends matters because unclear treatment trends ownership delays containment, investigation and restart. For hygiene and environment, retain a signed hygiene and environment comparison using common assumptions and stated exclusions. At packaging lot review, contain the packaging lot review event before unrepresentative packaging lot review can pass a convenient trial and fail in routine use.
Assign treatment trends to a named role with an escalation path and dated closure. Treatment trends risk: Unclear treatment trends ownership delays containment, investigation and restart. Detection and containment use the treatment trends owner, escalation route and closure entry.
Compare hygiene and environment options on the same assumptions and state every exclusion. Hygiene and environment risk: Non-comparable hygiene and environment options can make weaker evidence appear acceptable. Detection and containment use a signed hygiene and environment comparison using common assumptions and stated exclusions.
Verify packaging lot review with representative inputs, operators and credible operating variation. Packaging lot review risk: Unrepresentative packaging lot review can pass a convenient trial and fail in routine use. Detection and containment use the packaging lot review protocol, actual conditions, raw results and approval.
04
Retesting may be scientifically appropriate but cannot be used to test into compliance. Qualified quality personnel and applicable authority rules control confirmation, notification, disposition and release. Authorize affected-lot boundary from the affected-lot boundary trend, investigation trigger and dated review decision. Revisit root cause and capa whenever disconnected root cause and capa can expose product, people or continuity. Keep disposition approval open; the disposition approval project must approve disposition approval only when gaps are closed or retained as named, dated actions. Close disposition approval with the accepted disposition approval record with residual actions, owners and due dates.
Trend affected-lot boundary, define the investigation trigger and record the review decision. Acceptance relies on the affected-lot boundary trend, investigation trigger and dated review decision. Without affected-lot boundary trends, drift can outrun investigation. Reopen Affected-lot boundary when that condition occurs.
Connect loss of root cause and capa to product hold, safe state and continuity response. Acceptance relies on a cause-and-effect test linking root cause and capa loss to the intended response. Disconnected root cause and capa can expose product, people or continuity. Reopen Root cause and CAPA when that condition occurs.
Approve disposition approval only when gaps are closed or retained as named, dated actions. Acceptance relies on the accepted disposition approval record with residual actions, owners and due dates. Open disposition approval gaps can be mistaken for final acceptance. Reopen Disposition approval when that condition occurs.
R
These sources support the risk-control method on this page. They do not set project-specific legal limits, test frequencies, engineering values or approvals; verify the current edition and local applicability before a decision.
U.S. FDA
Codex Alimentarius
World Health Organization
Buyer questions
Document immediate batch hold from current site evidence; name the owner, source and review date. Keep the point open until its evidence owner and review date are named.
The controlled sample integrity revision and its requalification trigger. A file name alone does not prove the actual conditions, result or disposition.
Non-comparable hygiene and environment options can make weaker evidence appear acceptable. Contain affected product or people, trace the effects and authorize restart against the approved rule.
Assign it to a named role. Seek specialist, supplier or authority confirmation where the evidence crosses the project team’s competence boundary.
Move this project question forward
Control starts with treatment trends, passes through hygiene and environment, then tests packaging lot review. A failure of treatment trends matters because unclear treatment trends ownership delays containment, investigation and restart. For hygiene and environment, retain a signed hygiene and environment comparison using common assumptions and stated exclusions. At packaging lot review, contain the packaging lot review event before unrepresentative packaging lot review can pass a convenient trial and fail in routine use.
Not sure which data matters? Send what you have and state the decision you need to make.
Send target capacity and SKUs, source-water report, site utility schedule, building layout and required project milestones.
The project desk can identify missing inputs and a practical next step. Final engineering, configuration, compliance and commercial terms remain project-specific.
Allot Tech (Suzhou) Co., Ltd. · sales@allottech.com · Project telephone: +86 186 6213 1120 / +1 818 262 0958